Page last updated: 2024-11-08

beta-ionone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-ionone: stimulator of carotenogenesis; carotenoid inhibitor; intermediate in synthesis of Vit A; RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

beta-ionone : An ionone that is but-3-en-2-one substituted by a 2,6,6-trimethylcyclohex-1-en-1-yl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID638014
CHEMBL ID559945
CHEBI ID32325
SCHEMBL ID23953
MeSH IDM0051759

Synonyms (126)

Synonym
trans-.beta.-ionone
.beta.-ionone isomer # 2
3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (e)-
.beta.-ionone isomer # 1
3-buten-2-one,6,6-trimethyl-1-cyclohexen-1-yl)-
.beta.-ionone
.beta.-cyclocitrylideneacetone
wln: l6utj a1u1v1 b1 f1 f1
.beta.-ionene
4-(2,6-trimethyl-1-cyclohexenyl)-3-buten-2-one
4-(2,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
nsc-46137
4-(2,6-trimethyl-1-cyclohexen-l-yl)-3-buten-2-one
NSC46137 ,
ionone, .beta.-
ionone, beta
14901-07-6
(e)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
ccris 4289
einecs 201-224-3
beta-ionone (trans)
fema no. 2595
ai3-25073
b-ionone
(e)-beta-ionone
trans-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
brn 1909544
einecs 238-969-9
beta-cyclocitrylideneacetone
4-(2,6,6-trimethylcyclohex-1-ene-1-yl)-but-3-ene-2-one
nsc 402758
4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
4-(2,6,6-trimethyl-1-cyclohexenyl)-3-buten-2-one
ccris 6249
3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-
(3e)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one
3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (3e)-
inchi=1/c13h20o/c1-10-6-5-9-13(3,4)12(10)8-7-11(2)14/h7-8h,5-6,9h2,1-4h3/b8-7
nsc-402758
nsc402758
79-77-6
trans-beta-ionone
beta-ionone
3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (e)
(e)-4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one
beta-ionone, predominantly trans, >=97%, fcc, fg
beta-ionone, 96%
beta-ionone, natural, >=85%, fg
CHEBI:32325 ,
beta-ionon
beta-e-ionone
9-apo-beta-caroten-9-one
CHEMBL559945
STK801279
AKOS000121023
NCGC00248145-01
NCGC00248145-02
(e)-4-(2,6,6-trimethyl-1-cyclohexenyl)-but-3-en-2-one
hsdb 8269
ec 238-969-9
cas-79-77-6
dtxcid901769
tox21_302862
dtxsid4021769 ,
NCGC00256534-01
tox21_300709
tox21_201454
cas-14901-07-6
NCGC00259005-01
dtxcid3027952
NCGC00257517-01
BBL009828
AM806748
85949-43-5
einecs 288-959-3
4-(2,6,6-trimethyl-1(or 2)-cyclohexen-1-yl)-3-buten-2-one
ec 201-224-3
a7nrr1hlh6 ,
unii-a7nrr1hlh6
2-07-00-00140 (beilstein handbook reference)
4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one
.beta.-ionone [mi]
.beta.-ionone [fhfi]
(e)-.beta.-ionone
beta-ionone [fcc]
(e)-4-(2,6,6-trimethylcyclohex-1-enyl)but-3-en-2-one
(3e)-4-(2,6,6-trimethylcyclohex-1-en-1-yl) but-3-en-2-one
beta ionone
SCHEMBL23953
3-benzylamino-propionicacid
(e)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one
4-(2,6,6-trimethyl-1-cyclohexen-l-yl)-3-buten-2-one
4-(2,6,6-trimethyl-1-cyclohexene-1-yl)-3-buten-2-one
W-104258
mfcd00001549
bdbm181139
us9144538, beta-ionone
us9138393, ?-ionone
beta-ionone, analytical standard
?-ionone
beta-ionone, purum, >=95.0% (gc)
ss-ionone
AS-68699
beta-ionone, natural (us), >=85%, fg
[e]-4-[2,6,6-trimethyl-1-cyclohexen-1-yl]-3-buten-2-one
beta -e-ionone
4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-(e)-3-buten-2-one
(e)-beta -ionone
fema 2595
trans-beta -ionone
(3e)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one
J-008542
EN300-755077
F0451-1336
beta-ionone, synthetic
VS-02204
Q27114873
(3e)-beta-ionone
CS-W015800
D70747
F81525
HY-W015084
beta -ionone
EN300-18432
beta-cyclocitrylidenacetone
ionone, beta-

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" our present results suggest that beta-ionone may be a useful model inducer of P450 enzyme(s) in studying toxic mechanism of certain chemicals which require metabolic activation by P450s in mice."( Pretreatment of male BALB/c mice with beta-ionone potentiates thioacetamide-induced hepatotoxicity.
Gu, HK; Ha, CS; Jeong, TC; Kim, HC; Park, JI; Roh, JK; Yun, HI, 1999
)
0.85
" In conclusion, except for a higher embryolethality at a maternally toxic dose, BIO caused no embryotoxic effect over the dose range tested and the study NOAEL for maternal and developmental toxicity was 500 mg of BIO/ kg of body weight/day."( Study on the developmental toxicity of β-ionone in the rat.
De-Carvalho, RR; De-Oliveira, ACAX; Delgado, IF; Paumgartten, FJR; Pinto, FCM, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves of these four compounds are indicative of multiple binding sites and/or modes of interaction with ABCR."( Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease.
Molday, RS; Nathans, J; Sun, H, 1999
)
0.3
" Anticarcinogenic actions of these isoprenoids seem to follow a dose-response relationship."( Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
de Conti, A; de Moura Espíndola, R; Heidor, R; Mazzantini, RP; Moreno, FS; Ong, TP, 2005
)
0.65
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ionone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (9)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of fat-soluble vitamins2623
Retinoid metabolism and transport2217
Visual phototransduction6241
5-Deoxystrigol Biosynthesis410
carotenoid cleavage620
5-deoxystrigol biosynthesis310
Sensory Perception21568
5-deoxystrigol biosynthesis311
carotenoid cleavage422
Strigolactone biosynthesis27

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency30.51630.002541.796015,848.9004AID1347395; AID1347397; AID1347398
GLI family zinc finger 3Homo sapiens (human)Potency33.68100.000714.592883.7951AID1259369
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency76.95880.000657.913322,387.1992AID1259377
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency27.83450.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency31.48530.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.75320.000229.305416,493.5996AID743069; AID743075
thyroid stimulating hormone receptorHomo sapiens (human)Potency31.23080.001628.015177.1139AID1224843
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency10.962219.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.30600.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (50)

Assay IDTitleYearJournalArticle
AID431969Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID1090711Thrips luring activity against female Thrips tabaci (onion thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1331492Growth inhibition of human MDA-MB-435 cells at 100 uM after 7 days relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1090713Thrips luring activity against female New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1331499Antiproliferative activity against human LNCAP cells after 72 hrs by flow cytometry2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331495Inhibition of cell mitosis in human MDA-MB-435 cells after 48 hrs relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1434733Modulation of human SERT expressed in HEK293 cells at 0.1 uM using APP+ as substrate by fluorescence assay relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Nardonaphthalenones A and B from the roots and rhizomes of Nardostachys chinensis Batal.
AID1817851Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 25 uM measured after 24 hrs by Cell-titre blue assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Ligand-based rational design, synthesis and evaluation of novel potential chemical chaperones for opsin.
AID1331498Antiproliferative activity against human DU145 cells after 72 hrs by flow cytometry2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331482Growth inhibition of human SGC7901 cells at 25 uM after 8 days by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331511Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as inhibition of tumor formation at 18 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin staini2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331500Antiproliferative activity against human PC3 cells after 72 hrs by flow cytometry2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331480Growth inhibition of human SGC7901 cells at 200 uM after 24 to 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331479Growth inhibition of human SGC7901 cells at 100 uM after 24 to 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331484Growth inhibition of human SGC7901 cells at 100 uM after 8 days by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1090712Thrips luring activity against male New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1331490Growth inhibition of human MDA-MB-435 cells at 25 uM after 7 days relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1434734Modulation of human SERT expressed in HEK293 cells at 1 uM using APP+ as substrate by fluorescence assay relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Nardonaphthalenones A and B from the roots and rhizomes of Nardostachys chinensis Batal.
AID1817852Cytotoxicity against human ARPE-19 cells assessed as reduction in cell viability at 25 uM measured after 24 hrs by Cell-titre blue assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Ligand-based rational design, synthesis and evaluation of novel potential chemical chaperones for opsin.
AID555344Effect on growth in Staphylococcus aureus MN8 at 3.75 mM after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID1331477Growth inhibition of human SGC7901 cells at 25 uM after 24 to 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID555363Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.75 mM after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID1331496Inhibition of clone formation in human MDA-MB-435 cells after 48 hrs relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331494Growth inhibition of human MDA-MB-435 cells after 7 days relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331493Growth inhibition of human MDA-MB-435 cells at 200 uM after 7 days relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331481Growth inhibition of human SGC7901 cells after 24 to 48 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID431966Cytotoxicity against human LNCAP cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID1331503Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as tumor incidence at 36 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin staining based micro2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1817847Binding affinity to bovine opsin assessed as rate constant preincubated for 30 mins followed by 9-cis-retinol addition and measured after 30 mins by UV-visible spectra method2021European journal of medicinal chemistry, Dec-15, Volume: 226Ligand-based rational design, synthesis and evaluation of novel potential chemical chaperones for opsin.
AID1331489Induction of apoptosis in human MCF7 cells assessed as inhibition of DNA synthesis at 48 hrs relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1817848Half life of compound2021European journal of medicinal chemistry, Dec-15, Volume: 226Ligand-based rational design, synthesis and evaluation of novel potential chemical chaperones for opsin.
AID1331483Growth inhibition of human SGC7901 cells at 50 uM after 8 days by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID431968Cytotoxicity against human C4-2B cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID1331497Induction of apoptosis in human MDA-MB-435 cells assessed as inhibition of DNA synthesis after 48 hrs relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID431967Cytotoxicity against human 22Rv1 cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID1331501Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as tumor incidence at 9 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin staining based micros2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331502Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as tumor incidence at 18 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin staining based micro2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331478Growth inhibition of human SGC7901 cells at 50 uM after 24 to 48 hrs by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID555331Effect on growth in Staphylococcus aureus MN8 at 0.75 mM after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID431971Cytotoxicity against human PC3 cells at 150 uM after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID1331510Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as inhibition of tumor formation at 9 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin stainin2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331485Growth inhibition of human SGC7901 cells at 200 uM after 8 days by MTT assay relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331488Inhibition of cell mitosis in human MCF7 cells after 48 hrs relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331486Antiproliferative activity against human SGC7901 cells2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID431970Cytotoxicity against human MDA PCa 2b cells after 72 hrs by MTT assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.
AID555376Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 3.75 mM after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID1434736Modulation of human SERT expressed in HEK293 cells at 10 uM using APP+ as substrate by fluorescence assay relative to control2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Nardonaphthalenones A and B from the roots and rhizomes of Nardostachys chinensis Batal.
AID1331487Antiproliferative activity against human MCF7 cells2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331512Antitumor activity against DMBA-induced mammary carcinogenesis in Sprague-Dawley rat assessed as inhibition of tumor formation at 36 mmol/kg administered with AIN-76A diet treated 2 weeks prior to DMBA addition for 24 weeks by hematoxylin and eosin staini2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
AID1331491Growth inhibition of human MDA-MB-435 cells at 50 uM after 7 days relative to control2016European journal of medicinal chemistry, Nov-10, Volume: 123β-Ionone and its analogs as promising anticancer agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (259)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (5.79)18.7374
1990's23 (8.88)18.2507
2000's66 (25.48)29.6817
2010's109 (42.08)24.3611
2020's46 (17.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.78 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index76.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (2.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other259 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]